Viewing Study NCT01695135


Ignite Creation Date: 2025-12-24 @ 10:31 PM
Ignite Modification Date: 2026-01-15 @ 10:39 PM
Study NCT ID: NCT01695135
Status: COMPLETED
Last Update Posted: 2019-07-18
First Post: 2012-09-25
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy
Sponsor: Janssen Research & Development, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate neoplasms View
None Prostate cancer View
None Metastatic castration resistant prostate cancer View
None Abiraterone acetate View
None JNJ-212082 View